Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02413216 · ClinicalTrials.gov registry record · NA
TicHelper: A Computerized Comprehensive Behavioral Intervention for Tics (CBIT)
A NA study, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
NCT02413216: Completed NA study, sponsored by University of Utah.
NCT02413216 is a NA study that has completed, run by University of Utah. The registered enrollment target is 55 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02413216, a NA study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
Study Summary
Tic Disorders (including Tourette Disorder) are relatively common in school-age children and for some children can lead to significant psychosocial and physical impairment and diminished quality of life. Non-pharmacological treatments have been shown to be effective for reducing tics in some children. These treatment options are desired by parents, but are not widely available. The investigators recently developed an online, computerized, self-administered version of CBIT called TicHelper.com. The current study will test the efficacy of TicHelper.com in a randomized clinical trial.
Primary Outcome
Clinician interview to assess overall severity of tics
Interventions
- BEHAVIORAL TicHelper
- OTHER Internet Based Resources
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2015-08 |
| Est. Completion | 2017-08-31 |
| Phase | NA |
What the finished NCT02413216 record still lists
NCT02413216 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which TicHelper is the first listed.
NCT02413216 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02413216 about?
NCT02413216 is a clinical study titled "TicHelper: A Computerized Comprehensive Behavioral Intervention for Tics (CBIT)". Tic Disorders (including Tourette Disorder) are relatively common in school-age children and for some children can lead to significant psychosocial and physical impairment and diminished quality of life. Non-pharmacological treatments have been shown to be effective for reducing tics in some childre...
What is the current status of trial NCT02413216?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2015-08. Estimated completion is 2017-08-31.
What interventions are being tested in trial NCT02413216?
The interventions under investigation include: TicHelper (BEHAVIORAL), Internet Based Resources (OTHER).
Who is sponsoring clinical trial NCT02413216?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02413216's enrollment target sits among peer trials
55 1264th of 2000 higher than 733 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia